Allowing Biological E’s Corbevax as a booster for those fully vaccinated against COVID-19 with either Covishield or Covaxin and reducing the gap between the second dose and the precaution dose of the vaccines to six months are among the issues likely to be discussed at a meeting of the NTAGI to be held soon. The … Read more
The NTAGI will discuss on Wednesday whether to allow early administration of the precaution dose of COVID-19 vaccine to those travelling abroad for education, employment, sporting events and business commitments. The advisory panel is also likely to deliberate on reducing the gap between the second dose of COVID-19 vaccine and the precaution dose from the … Read more
The Standing Technical Sub-Committee of the NTAGI has recommended inclusion of the Serum Institute’s Covovax in the national COVID-19 vaccination programme for children aged 12 to 17 years, sources said on Friday. India’s drug regulator had approved Covovax for restricted use in emergency situations in adults on December 28 last year and in the 12-17 … Read more
Covid working group of NTAGI will review this week data of Serum Institute of India’s (SII) anti-coronavirus jab Covovax to decide whether it can be included in the national COVID-19 vaccination programme for inoculating those aged 12 years and above, official sources said on Wednesday. India’s drug regulator had approved Covovax for restricted use in … Read more
Civid-19 vaccintion for adoloscents to start by September (Image : Pixabay) As Covid-19 vaccine doses for children are in the offing before the third wave of pandemic kicks in, the National Immunization Technical Advisory Group (NTAGI) recently informed that children above the age of 12 with comorbidities will be given priority for immunization. The Drug … Read more
It will also look at ensuring that sufficient volumes of the vaccine are manufactured to meet India’s COVID-19 vaccine requirement. ‘Mission COVID Suraksha’: The government has proposed setting up a ‘Mission COVID Suraksha’ with a corpus of Rs 3,000 crore to accelerate the development and manufacture of safe and effective COVID-19 vaccines in the country, … Read more